Umlaut.Bio

Umlaut.Bio is a spinout of the EMBL, is pursuing tRNA targets for treatment of cancer and immunological diseases.

Health and bio

Umlaut.Bio has no funding amount on record yet; its latest known round is Pre Seed (Feb 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. February 20, 2026
   Pre Seed · amount undisclosed
   Source: crunchbase.com

Related other companies

• WWedding WeekenderOct 1, 2026
• RR2CreteOct 1, 2026
• AAdaptCloseSep 30, 2026
• EElredo VoiceSep 29, 2026
• FFIG LivingSep 29, 2026
• PPakajoSep 29, 2026
• NNovuxSep 29, 2026
• MMurrmurSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/umlaut-bio.